These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 622503)

  • 1. Dose distribution around an 125I seed source in tissue.
    Krishnaswamy V
    Radiology; 1978 Feb; 126(2):489-91. PubMed ID: 622503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose tables for 125I seed implants.
    Krishnaswamy V
    Radiology; 1979 Sep; 132(3):727-30. PubMed ID: 472255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The exposure rate constant for a silver wire 125I seed.
    Hashemi AM; Mills MD; Hogstrom KR; Almond PR
    Med Phys; 1988; 15(2):228-34. PubMed ID: 3386595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-dimensional dose distribution around a commercial 125I seed.
    Burns GS; Raeside DE
    Med Phys; 1988; 15(1):56-60. PubMed ID: 3352551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-dimensional dose distribution of 125I seeds.
    Ling CC; Schell MC; Yorke ED; Palos BB; Kubiatowicz DO
    Med Phys; 1985; 12(5):652-5. PubMed ID: 4047002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the radial function on I-125 seeds used for permanent prostate implantation.
    Pickett B; Pouliot J
    Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose distribution for 125I implants due to anisotropic radiation emission and unknown seed orientation.
    Prasad SC; Bassano DA; Fear PI
    Med Phys; 1987; 14(2):296-8. PubMed ID: 3587158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the IsoAid ADVANTAGE (125)I brachytherapy source dosimetric parameters using Monte Carlo simulation.
    Sadeghi M; Hamed Hosseini S
    Appl Radiat Isot; 2010 Jan; 68(1):211-3. PubMed ID: 19762248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The three-dimensional dose distribution of 125I seeds in tissue.
    Hartmann GH; Schlegel W; Scharfenberg H
    Phys Med Biol; 1983 Jun; 28(6):693-9. PubMed ID: 6878427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric characteristic of a new 125I brachytherapy source.
    Sadeghi M; Khanmohammadi Z
    Radiat Prot Dosimetry; 2011 Nov; 147(3):451-6. PubMed ID: 21233096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved treatment planning for COMS eye plaques.
    Astrahan MA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1227-42. PubMed ID: 15752905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung density effect on 125I dose distribution.
    Prasad SC; Bassano DA; Perg JG
    Med Phys; 1985; 12(1):99-100. PubMed ID: 3974533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Brachytherapy of ocular melanoma: physical and dosimetric aspects of 125I plaques].
    Bard JJ
    Bull Cancer Radiother; 1995; 82(3):295-305. PubMed ID: 8554879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation exposure to medical personnel during iodine-125 seed implantation of the prostate.
    Liu J; Edwards FM
    Radiology; 1979 Sep; 132(3):748-9. PubMed ID: 472263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A dose table describing fractions of peripheral volume for 125I volume implants.
    Rosemark PJ; Tobochnik N; Herman MW; Whiting JS; Thompson RW; Weisenburger TH; Metcalf DR; Greenfield MA
    Radiology; 1982 Feb; 142(2):517-20. PubMed ID: 7054846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Basis for the use of enclosed 125I sources for interstitial radiation therapy].
    Volkov AA; Gubareva AV; Gusel'nikov VS; Zaĭtsev VM; Kaganskiĭ VL
    Med Radiol (Mosk); 1985 Aug; 30(8):30-4. PubMed ID: 4033388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the dose in permanent implants of I-125].
    Piermattei A; Arcovito G; Andreasi Bassi F; D'Abramo G
    Radiol Med; 1985 Sep; 71(9):626-9. PubMed ID: 4089261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The robustness of dose distributions to displacement and migration of 125I permanent seed implants over a wide range of seed number, activity, and designs.
    Beaulieu L; Archambault L; Aubin S; Oral E; Taschereau R; Pouliot J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1298-308. PubMed ID: 15001275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monte Carlo calculations and TLD measurements to determine the two-dimensional dosage distribution of 125-iodine seed, Model 6702].
    Vogelgesang U; Wiesen G; Leetz HK
    Strahlenther Onkol; 1990 Jul; 166(7):470-7. PubMed ID: 2382210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of gel dosimetry to measure the 3D dose distribution of a 90Sr/90Y intravascular brachytherapy seed.
    Massillon-Jl G; Minniti R; Mitch MG; Maryanski MJ; Soares CG
    Phys Med Biol; 2009 Mar; 54(6):1661-72. PubMed ID: 19242054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.